Lexicon Pharmaceuticals

LXRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.097 B

$2.47 +4.66%

Close of 7 Aug 2026

Revenue

$49.8M

#2743 by revenue

Earnings

-$50.3M

Loss-making

Shares outstanding

444,955,934

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#154InventivaIVA$1.13B
#155Alto NeuroscienceANRO$1.11B
#156Lexicon PharmaceuticalsLXRX$1.10B
#157Jade BiosciencesJBIO$1.08B
#158Olema PharmaceuticalsOLMA$1.05B

Where these numbers come from

Share counts and financials for Lexicon Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.